tradingkey.logo
tradingkey.logo
Search

Neurosense Therapeutics Ltd

NRSN
Add to Watchlist
0.465USD
-0.011-2.27%
Close 07-31 16:00ETQuotes delayed by 15 min
15.15MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Ben-Noon (Alon)
11.82%
Rimon Gold Assets Ltd
9.34%
Eisenberg (Or)
3.55%
Tracik (Ferenc)
1.75%
Binder (Hagit)
1.44%
Other
72.11%
Shareholders
Shareholders
Proportion
Ben-Noon (Alon)
11.82%
Rimon Gold Assets Ltd
9.34%
Eisenberg (Or)
3.55%
Tracik (Ferenc)
1.75%
Binder (Hagit)
1.44%
Other
72.11%
Shareholder Types
Shareholders
Proportion
Individual Investor
22.97%
Corporation
9.34%
Investment Advisor/Hedge Fund
0.41%
Investment Advisor
0.37%
Hedge Fund
0.15%
Bank and Trust
0.10%
Family Office
0.05%
Other
66.61%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
33
367.79K
1.04%
-2.01M
2025Q4
30
293.14K
0.99%
-2.10M
2025Q3
29
437.13K
1.75%
-1.60M
2025Q2
37
7.64M
31.03%
+143.76K
2025Q1
39
7.45M
37.28%
+353.50K
2024Q4
38
7.90M
34.02%
+1.29M
2024Q3
32
5.18M
22.45%
-1.31M
2024Q2
35
6.62M
30.57%
+1.57M
2024Q1
38
5.18M
33.20%
-953.28K
2023Q4
38
5.12M
32.81%
-1.05M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Ben-Noon (Alon)
3.18M
9.51%
+93.67K
+3.04%
Apr 07, 2025
Rimon Gold Assets Ltd
2.30M
6.9%
+2.30M
--
Dec 02, 2024
Eisenberg (Or)
480.92K
1.44%
+20.92K
+4.55%
Apr 07, 2025
Tracik (Ferenc)
189.62K
0.57%
+66.67K
+54.22%
Apr 07, 2025
Binder (Hagit)
232.00K
0.69%
+200.00K
+625.00%
Mar 26, 2026
Russek-Blum (Niva)
275.43K
0.82%
+200.00K
+265.15%
Mar 26, 2026
Leuchtenberger (Mark W)
64.00K
0.19%
--
--
Apr 07, 2025
Claiborne (Cary J)
24.00K
0.07%
--
--
Apr 07, 2025
Pellizzari (Christine)
24.00K
0.07%
--
--
Apr 07, 2025
Mandil-Levin (Revital Ph.D.)
28.53K
0.09%
--
--
Apr 07, 2025
View more
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.